Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

510.38
-5.0800-0.99%
Post-market: 510.380.00000.00%19:30 EDT
Volume:538.52K
Turnover:275.07M
Market Cap:21.89B
PE:18.26
High:515.55
Open:510.95
Low:507.03
Close:515.46
52wk High:609.35
52wk Low:375.61
Shares:42.89M
Float Shares:39.35M
Volume Ratio:1.27
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.42
PE(LYR):18.32

Loading ...

United Therapeutics reports Q1 EPS $5.82, consensus $6.86

TIPRANKS
·
May 07

United Therapeutics’ Earnings Call Signals Next Growth Phase

TIPRANKS
·
May 07

United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares worth $5.43 million

Reuters
·
May 07

MannKind Q1 revenue rises 15% but swings to net loss

Reuters
·
May 07

MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged

TIPRANKS
·
May 07

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber

Reuters
·
May 06

United Therapeutics Q1 Earnings, Revenue Fall

MT Newswires Live
·
May 06

BUZZ-MannKind rises as it partners with United Therapeutics on inhaled drug for rare lung disease

Reuters
·
May 06

Earnings Flash (UTHR) United Therapeutics Posts Q1 EPS $5.82, vs. FactSet Est of $6.91

MT Newswires Live
·
May 06

MannKind Corp - Eligible for up to $35 Mln in Milestones and 10% Royalties on Net Sales

THOMSON REUTERS
·
May 06

MannKind Corp - Announces Development of Ralinepag Dry Powder Inhalation for United Therapeutics

THOMSON REUTERS
·
May 06

United Therapeutics Q1 FY26 net income drops 15% to $274.9 million; revenue slips 2% to $781.5 million

Reuters
·
May 06

BRIEF-United Therapeutics Q1 Revenue USD 781.5 Million Vs. IBES Estimate USD 796.9 Million

Reuters
·
May 06

United Therapeutics Corporation Reports First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 06

United Therapeutics Q1 EPS USD 5.82

THOMSON REUTERS
·
May 06

United Therapeutics CFO James Edgemond disposes 10,000 shares for $5.77 million

Reuters
·
May 06

United Therapeutics CEO Martine Rothblatt disposes of shares worth $5.41 million

Reuters
·
May 05

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.41 million

Reuters
·
May 02

United Therapeutics CFO James Edgemond disposes of shares worth $5.01 million

Reuters
·
May 02

United Therapeutics CEO Martine Rothblatt disposes of shares worth $3.37 million

Reuters
·
May 01